Normal and cancerous mammary stem cells evade interferon-induced constraint through the MIR-199a-LCOR axis

Nature Cell Biology

Volumn 19, Issue 6, 2017, Pages 711-723

  Celià Terrassa, Toni ^a   Liu, Daniel D ^a   Choudhury, Abrar ^a   Hang, Xiang ^a   Wei, Yong ^a   Zamalloa, Jose ^a   Alfaro Aco, Raymundo ^a   Chakrabarti, Rumela ^a   Jiang, Yi Zhou ^b,c   Koh, Bong Ihn ^a   Smith, Heath A ^a   Decoste, Christina ^a   Li, Jun Jing ^b,c   Shao, Zhi Ming ^b,c   Kang, Yibin ^a  

^a PRINCETON UNIVERSITY   (United States)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKERATIN 14; MICRORNA; MICRORNA 199A; NUCLEAR RECEPTOR COREPRESSOR; TRANSFORMING GROWTH FACTOR BETA; TWIST RELATED PROTEIN 1; UNCLASSIFIED DRUG; INTERFERON; LCOR PROTEIN, HUMAN; MIRN199 MICRORNA, HUMAN; MIRN199 MICRORNA, MOUSE; MLR2 PROTEIN, MOUSE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; BREAST CELL; CELL AGING; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL SELF-RENEWAL; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; BREAST TUMOR; C57BL MOUSE; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; CELL SELF-RENEWAL; CELL TRANSFORMATION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HUMAN; MAMMARY GLAND; MCF-7 CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; PHENOTYPE; TRANSGENIC MOUSE; UDDER;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SELF RENEWAL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELA CELLS; HUMANS; INTERFERONS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MCF-7 CELLS; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PHENOTYPE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR MICROENVIRONMENT;

EID: 85020309665     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3533     Document Type: Article

References (70)

1. Visvader, J. E. & Stingl, J. Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev. 28, 1143-1158 (2014).
2. Nguyen, L. V., Vanner, R., Dirks, P. & Eaves, C. J. Cancer stem cells: an evolving concept. Nat. Rev. Cancer 12, 133-143 (2012).
3. Chakrabarti, R. et al. 1Np63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling. Nat. Cell Biol. 16, 1004-1015 (2014).
4. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028 (2012).
5. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009).
6. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507 (2008).
7. Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).
8. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003).
9. Liu, S. et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2, 78-91 (2014).
10. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
11. Gyorki, D. E., Asselin-Labat, M. L., van Rooijen, N., Lindeman, G. J. & Visvader, J. E. Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Res. 11, R62 (2009).
12. Drukker, M. & Benvenisty, N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22, 136-141 (2004).
13. Cordon-Cardo, C. et al. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res. 51, 6372-6380 (1991).
14. Bruttel, V. S. & Wischhusen, J. Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape Front. Immunol. 5, 360 (2014).
15. Gangaraju, V. K. & Lin, H. MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10, 116-125 (2009).
16. Lujambio, A. & Lowe, S. W. The microcosmos of cancer. Nature 482, 347-355 (2012).
17. Pal, B. et al. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits. Breast Cancer Res. 17, 85 (2015).
18. Greene, S. B., Gunaratne, P. H., Hammond, S. M. & Rosen, J. M. A putative role for microRNA-205 in mammary epithelial cell progenitors. J. Cell Sci. 123, 606-618 (2010).
19. Ibarra, I., Erlich, Y., Muthuswamy, S. K., Sachidanandam, R. & Hannon, G. J. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev. 21, 3238-3243 (2007).
20. Llobet-Navas, D. et al. The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev. 28, 765-782 (2014).
21. Ucar, A. et al. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat. Genet. 42, 1101-1108 (2010).
22. Bockmeyer, C. L. et al. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res. Treat. 130, 735-745 (2011).
23. Dvinge, H. et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497, 378-382 (2013).
24. Zhu, M. et al. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome Biol. 12, R77 (2011).
25. Liu, S., Clouthier, S. G. & Wicha, M. S. Role of microRNAs in the regulation of breast cancer stem cells. J. Mammary Gland Biol. Neoplasia 17, 15-21 (2012).
26. Plaks, V. et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Rep. 3, 70-78 (2013).
27. Lim, E. et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 12, R21 (2010).
28. Gupta, P. B. et al. Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 138, 645-659 (2009).
29. Visvader, J. E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 23, 2563-2577 (2009).
30. Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome geneexpression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl Acad. Sci. USA 107, 15449-15454 (2010).
31. Lee, Y. B. et al. Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res. 37, 123-128 (2009).
32. Beck, B. et al. Different levels of Twist1 regulate skin tumor initiation, stemness, and progression. Cell Stem Cell 16, 67-79 (2015).
33. Celia-Terrassa, T. et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Invest. 122, 1849-1868 (2012).
34. Ocana, O. H. et al. Metastatic colonization requires the repression of the epithelialmesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724 (2012).
35. Cho, R. W. et al. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26, 364-371 (2008).
36. DeRose, Y. S. et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 17, 1514-1520 (2011).
37. Buffa, F. M. et al. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res. 71, 5635-5645 (2011).
38. Jiang, Y. Z. et al. Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value. Cancer Res. 76, 2105-2114 (2016).
39. Calderon, M. R. et al. Ligand-dependent corepressor (LCoR) recruitment by Kruppellike factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene. J. Biol. Chem. 287, 8662-8674 (2012).
40. Fernandes, I. et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and-independent mechanisms. Mol. Cell 11, 139-150 (2003).
41. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913 (2009).
42. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
43. Liu, R. et al. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. Oncotarget 7, 56628-56642 (2016).
44. Yin, G. et al. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29, 3545-3553 (2010).
45. Alemdehy, M. F. et al. ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation. Blood 125, 3937-3948 (2015).
46. Cuiffo, B. G. et al. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell 15, 762-774 (2014).
47. Chen, J. et al. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. BMC Cancer 16, 887 (2016).
48. Asim, M. et al. Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase. J. Biol. Chem. 286, 37108-37117 (2011).
49. Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224-1231 (2012).
50. Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J. & Kroemer, G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405-414 (2015).
51. McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O'Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87-103 (2015).
52. Essers, M. A. et al. IFN activates dormant haematopoietic stem cells in vivo. Nature 458, 904-908 (2009).
53. Sato, T. et al. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 15, 696-700 (2009).
54. Schedin, P. Pregnancy-associated breast cancer and metastasis. Nat. Rev. Cancer 6, 281-291 (2006).
55. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750-2767 (2011).
56. Celia-Terrassa, T. & Kang, Y. Distinctive properties of metastasis-initiating cells. Genes Dev. 30, 892-908 (2016).
57. Malladi, S. et al. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165, 45-60 (2016).
58. Schatton, T., Frank, N. Y. & Frank, M. H. Identification and targeting of cancer stem cells. Bioessays 31, 1038-1049 (2009).
59. Eriksson, M. et al. Oncolytic adenoviruses kill breast cancer initiating CD44CCD24=low cells. Mol. Ther. 15, 2088-2093 (2007).
60. James, C. D. et al. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res. 51, 1684-1688 (1991).
61. Lu, R., Au, W. C., Yeow, W. S., Hageman, N. & Pitha, P. M. Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation. J. Biol. Chem. 275, 31805-31812 (2000).
62. Shackleton, M. et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88 (2006).
63. Behan, J. W. et al. Activation of adipose tissue macrophages in obese mice does not require lymphocytes. Obesity 21, 1380-1388 (2013).
64. Shultz, L. D. et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180-191 (1995).
65. Chakrabarti, R. et al. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat. Cell Biol. 14, 1212-1222 (2012).
66. Karantza-Wadsworth, V. & White, E. A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression. Methods Enzymol. 446, 61-76 (2008).
67. Bonnefoy, F. et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J. Immunol. 186, 5696-5705 (2011).
68. Choi, Y. S., Chakrabarti, R., Escamilla-Hernandez, R. & Sinha, S. Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev. Biol. 329, 227-241 (2009).
69. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).
70. Ritchie, M. E. et al. Limma powers differential expression analyses for RNAsequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).